Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukocyte trafficking refers to the highly regulated process by which white blood cells (leukocytes) move throughout the body. This movement is essential for immune surveillance, homeostasis, and response to infection or injury. The process involves multiple steps: leukocytes exit the bone marrow, circulate in the blood and lymphatic systems, migrate into tissues during steady-state conditions or inflammation, and return via lymphatics or re-enter circulation. It is orchestrated through a cascade involving capture & rolling, activation, adhesion, crawling & transmigration (diapedesis), involving key molecules such as selectins, integrins, chemokines/chemokine receptors, and ICAMs/VCAMs. Dysregulation contributes to chronic inflammatory diseases, autoimmune disorders, cancer metastasis, and graft-versus-host disease.
Not applicable for a biological process; however, therapies targeting components of the process (e.g., integrins) act by blocking adhesion and transmigration of leukocytes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukocyte Trafficking (None).